Alfred E. Mann has been a significant figure in the biotechnology and medical device industries for decades. He founded MannKind Corporation, which specializes in diabetes treatment, and has also been involved in several other ventures like MiniMed, Advanced Bionics, and...
Alfred E. Mann has been a significant figure in the biotechnology and medical device industries for decades. He founded MannKind Corporation, which specializes in diabetes treatment, and has also been involved in several other ventures like MiniMed, Advanced Bionics, and Pacesetter Systems. With a strong background in physics from UCLA, he has leveraged his knowledge to create innovative medical solutions. Notably, Alfred was the largest shareholder of MannKind, holding approximately 154 million shares at one point, demonstrating significant personal investment in the company’s success. He even made headlines with his insider trading, engaging in substantial stock sales valued at over a million dollars during peak periods. With a no-nonsense compensation approach, Mann reported a salary from the company while emphasizing a philosophy focused on aligning executive interests with those of shareholders. Throughout his career, he has created and led companies that have addressed critical medical needs, showcasing a unique blend of engineering expertise and entrepreneurial spirit.